as hyperglycaemic emergencies. 8 This prompted an evaluation of the reasons for, and financial costs of, hyperglycaemic admissions to GFJH. The purpose of the study was to gather data that would inform the development of appropriate primary-and secondarylevel health care initiatives. This will allow reallocation of finances from inpatient hyperglycaemic emergencies to the primary level prevention of diabetic complications.
Methods
We conducted a prospective survey of all hyperglycaemic emergencies admitted to GFJH from 1 September to 31 October 2005. A hyperglycaemic emergency was defined as any patient with an elevated blood glucose concentration, and the perceived need by the admitting doctor to initiate intravenous insulin and fluid therapy. 9, 10 All hyperglycaemic emergencies were admitted to the HCU in order to ensure 2-hourly monitoring and supervision of intravenous insulin and fluid therapy; a lack of sufficient nursing staff in the general medical wards precludes such intensive monitoring. An intern was responsible for the daily management of these patients, while the medical registrar on call attended to problems after hours. Specialist physicians conducted daily HCU ward rounds. Because of limited nursing staff, minimal diabetic education was offered to hyperglycaemic patients admitted to GFJH.
Hyperglycaemic emergencies were classified according to the American Diabetes Association's classification of hyperglycaemic emergencies. 11 A further category, hyperosmolar diabetic ketoacidosis (HODKA), was added in this study because the measured outcomes in this group differed from those observed in the diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemic state (HHS) groups. Data collected for each patient included demographic group, and reason for, duration of and primary outcome of admission. HbA1c on admission is not a routine investigation in our setting because of cost constraints, and therefore did not form part of our analyses. Cost calculations were determined using the following formulae: (i) total costs = patient-specific costs + non-patient-specific costs; (ii) patient-specific costs = medication costs + laboratory costs + imaging costs + procedure costs + clinical staff costs; (iii) nonpatient-specific costs = capital costs + overhead costs; and (iv) capital costs = building costs + equipment costs. All costs were calculated utilising public-sector pricing. Patient-specific costs were determined using the 'ingredients approach', which involves identifying the specific components of all services utilised during admission. 12 Data were collected for each component of the patient's hospital admission (emergency unit (EU), HCU, GFJH medical ward and Carnation ward) -duration of stay, duration of doctor consultation, quantities and types of medication, laboratory investigations, X-rays and procedures utilised. Clinical staff costs were calculated per EU visit and per inpatient day. The estimated annual nursing cost was calculated as the product of annual cost per nursing shift group and the number of shift groups required per annum. The daily nursing cost was obtained by dividing the annual nursing cost by 365. Doctors' estimated annual cost was determined as the sum of their basic salary, overtime and scarce-skills allowance. Doctors' costs were calculated per hourly consultation with the patient. Non-patient-specific costs (i.e. capital costs and overhead costs) were obtained from a costing audit of HIV/AIDS admissions to GFJH in 2003/2004. 13 
Results
There were 53 hyperglycaemic emergencies admitted during the 2-month survey period (Table I) The mean duration of hospital stay was 4 days, and the overall in-hospital mortality of hyperglycaemic emergencies was 7.5% (Table I) We obtained all necessary data for cost calculation for 47 of the 53 hyperglycaemic emergency cases admitted. The mean cost per hyperglycaemic admission was R5 309; this varied according to the type of hyperglycaemic emergency (Table II) . SDKA and HODKA admissions had higher mean patientspecific and clinical staff costs compared with other groups. Discussion (Table IV) It is alarming to note that despite 'improved' access to primary health care facilities in South Africa, the number and profile of hyperglycaemic emergencies admitted to large public hospitals remains unchanged from studies conducted 10 -20 years ago. The number of hyperglycaemic emergencies admitted per month in our study (approximately 26) is similar to data obtained from studies conducted at Groote Schuur Hospital (GSH) in 1991 9 and Baragwanath Hospital (BH) in 1986. 10 However, as the sizes of the drainage populations in these two previous studies are not known, incidence comparisons are not possible. GSH study -sepsis (47%) and non-compliance (26%) -remain unchanged in our study. The in-hospital mortality rates were 9.1% for GSH (1991) 9 and 10.4% for BH (1986). 10 Our mean in-hospital mortality rate of 7.5%, and the mortality rate reported in a more recent study of hyperglycaemic emergencies admitted to BH (6.8% for DKA patients and 16.6% for HHS patients), 15 suggests that mortality rates may be declining. It is encouraging to note that the latest BH data are almost comparable to data reported by experienced centres in the USA (3.4 -4.6% for DKA and 15% for HHS). 16 A shorter duration of admission was found in our study (Table II) compared with hyperglycaemic admissions to GSH (7 -9 days). 9 This could be attributed to the medical bed pressure experienced at GFJH. 17 This is the first South African study evaluating the financial costs of hyperglycaemic admissions. The mean inpatient cost per hyperglycaemic emergency admission was estimated to be just over R5 300 (the equivalent of US$757, using an exchange rate of R7 per US$1 in September 2005). This figure is unacceptably high, given the potentially preventable nature of the problem. Comparatively, in 2005, the mean inpatient HIV/AIDS admission cost at GFJH was estimated at R4 630 (adjusted for inflation), 13 while diabetic hyperglycaemic emergencies admitted to USA hospitals in 2003 cost US$6 500 -13 000 per patient. 18, 19 It could be argued that we have overestimated the cost of hyperglycaemic emergency admissions, since our patients were admitted to a HCU. However, our data indicate that a substantial portion of the HCU cost was derived from medication, laboratory test monitoring and nursing care (50%). If these patients were admitted directly to the general wards, as is common practice elsewhere, these costs would still be applicable since acutely ill patients require more medication, monitoring and nursing care regardless of their location within a hospital. From the limited data obtained in our study, it appears that hyperglycaemic emergencies precipitated by gangrene may be associated with a much longer duration of hospital stay, and cost per admission, compared with other hyperglycaemic admissions. More data are required to validate this finding.
Recommendations
Preventive health care initiatives are urgently needed at a primary and secondary-care level. Primary care objectives should include: (i) early diagnosis of diabetes; (ii) timely identification and treatment of precipitating causes of hyperglycaemia; and (iii) education to improve compliance with diabetic treatment. Diabetic health education should ideally be offered to patients in their home language. Given the results of our survey, and the demographic profile of South Africans, 20 this is unlikely to be English; trained and motivated staff who engage patients in their home language and with culturally appropriate tools, is therefore a priority. In addition, another important reason for non-compliance with antihyperglycaemic therapy, i.e. poor access to medication from community health care centres because of long waiting times and non-availability of drugs, needs to be addressed.
We need to implement cost-effective strategies that improve the quality of inpatient care and outcome of admissions. Firstly, we need to target the high medical sepsis mortality with earlier diagnosis and treatment at primary-care level. Secondly, relevant diabetic education needs to be provided to all hyperglycaemic emergency patients, in their home language, before discharge. Thirdly, a survey of surgical sepsis, specifically gangrene, needs to be conducted to determine whether inpatient admission duration and costs in this group can be reduced significantly.
In conclusion, South Africa is a resource-limited nation with a quadruple burden of disease. With the advent of district-based health care systems in South Africa the onus is on districts to determine costeffective approaches to treating illnesses that cause significant morbidity and mortality. The potential adverse outcomes and high costs of hyperglycaemic emergency admissions necessitate cost-effective approaches at primary-care level to prevent these admissions.
